Selectis Health, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.0M | $-2.4M | $-4.0M | $-2.4M | $-2.3M | $3.0M | $-861.6K | $-2.0M |
| Depreciation & Amortization | $1.5M | $1.6M | $1.7M | $1.8M | $1.7M | $1.6M | $1.4M | — |
| Depreciation | — | — | $1.7M | $1.8M | $1.7M | $1.5M | $1.3M | $1.3M |
| Amortization | $16.7K | $103.4K | $347.8K | $316.0K | $157.3K | $121.9K | $26.9K | — |
| Stock-Based Compensation | — | — | — | — | $18.7K | $-8.8K | — | $135.0K |
| Net Cash from Operating Activities | $1.9M | $-1.8M | $536.7K | $-305.1K | $-270.9K | $2.7M | $868.9K | $108.2K |
| Investing Activities | ||||||||
| Capital Expenditures | $443.6K | $36.1K | $29.8K | $222.4K | $519.6K | $985.7K | $1.7M | $763.3K |
| Business Acquisitions | — | — | — | — | — | $1.0M | $734.2K | — |
| Net Cash from Investing Activities | $-443.6K | $2.4M | $-29.8K | $-222.4K | $-519.6K | $-1.6M | $-2.4M | $-595.2K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | $101.6K | — | $132.8K |
| Net Cash from Financing Activities | $-976.7K | $-1.5M | $-618.7K | $-1.8M | $1.6M | $1.8M | $1.2M | $822.0K |
| Net Change in Cash | $461.7K | $-912.8K | $-111.9K | $-2.4M | $814.8K | $3.0M | $-314.7K | $335.1K |
| Free Cash Flow | $1.4M | $-1.9M | $506.9K | $-527.5K | $-790.5K | $1.7M | $-799.9K | $-655.1K |